Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov 18:12:1729-1748.
doi: 10.2147/TCRM.S115902. eCollection 2016.

Intestinal permeability in a patient with liver cirrhosis

Affiliations
Review

Intestinal permeability in a patient with liver cirrhosis

Jonathan Manuel Aguirre Valadez et al. Ther Clin Risk Manag. .

Abstract

Liver cirrhosis is a worldwide public health problem, and patients with this disease are at high risk of developing complications, bacterial translocation from the intestinal lumen to the mesenteric nodes, and systemic circulation, resulting in the development of severe complications related to high mortality rate. The intestinal barrier is a structure with a physical and biochemical activity to maintain balance between the external environment, including bacteria and their products, and the internal environment. Patients with liver cirrhosis develop a series of alterations in different components of the intestinal barrier directly associated with the severity of liver disease that finally increased intestinal permeability. A "leaky gut" is an effect produced by damaged intestinal barrier; alterations in the function of tight junction proteins are related to bacterial translocation and their products. Instead, increasing serum proinflammatory cytokines and hemodynamics modification, which results in the appearance of complications of liver cirrhosis such as hepatic encephalopathy, variceal hemorrhage, bacterial spontaneous peritonitis, and hepatorenal syndrome. The intestinal microbiota plays a fundamental role in maintaining the proper function of the intestinal barrier; bacterial overgrowth and dysbiosis are two phenomena often present in people with liver cirrhosis favoring bacterial translocation. Increased intestinal permeability has an important role in the genesis of these complications, and treating it could be the base for prevention and partial treatment of these complications.

Keywords: bacterial translocation; hepatic encephalopathy; intestinal permeability; liver cirrhosis; spontaneous bacterial peritonitis; variceal hemorrhage.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Components of the intestinal barrier. It is composed of intestinal microbiota, a mucin layer with IgA immunoglobulin (and other defense proteins) covering the mixed columnar epithelial cells (enterocytes, globet cells, enterochromaffin cells and intestinal stem cells). Subepithelial region containing the lamina propria, the enteric nervous system, connective tissue and muscle layers. Intraepithelial lymphocytes are above, underlying basement membrane. There are many differents immune cells, like macrophages, dendritic cells, plasma cells, lymphocytes and in some cases, neutrophils, and organized lymphoid tissue like lymphoid structures compound as the Peyer’s patch (terminal ileum), containing M cells, dendritic cells and lymphocytes. Note: Adapted with permission from Salvo-Romero E, Alonso Cotoner C, Pardo-Camacho C, et al. The intestinal barrier function and its involvement in digestive disease. Rev Esp Enferm Dig. 2015;107:686–696. Abbreviations: CNS, central nervous system; ENS, enteric nervous system; IEC, intestinal epithelial cell; IESC, intestinal epithelial stem cell; IgA, immunoglobulin A; EC, enterochromaffin cell; DC, dendritic cells; PC, plasma cell.

Similar articles

Cited by

References

    1. Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;13:1279–1290. - PubMed
    1. Munoz SJ. Hepatic encephalopathy. Med Clin North Am. 2008;92(4):795–812. - PubMed
    1. Olson J, Wendon JA, Kramer DJ, et al. Intensive care of the patient with cirrhosis. Hepatology. 2011;54(5):1864–1872. - PubMed
    1. Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol. 2012;590(3):447–458. - PMC - PubMed
    1. Pleguezuelo M, Benitez JM, Jurado J. Diagnosis and management of bacterial infections in decompensated cirrhosis. World J Hepatol. 2013;27:6–25. - PMC - PubMed

LinkOut - more resources